This trial is studying whether the M6-C artificial cervical disc is safe and effective compared to anterior cervical discectomy and fusion for treating 2-level cervical radiculopathy.
5 Primary · 7 Secondary · Reporting Duration: 24 Month
Active Control
Experimental Treatment
263 Total Participants · 3 Treatment Groups
Primary Treatment: M6-C Artificial Cervical Disc · No Placebo Group · N/A
Age 18 - 75 · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:California | 50.0% |
New York | 50.0% |
65+ | 50.0% |
18 - 65 | 50.0% |
Memorial Orthopaedic Surgical Group | 50.0% |
Upstate Medical University | 50.0% |
Met criteria | 100.0% |